In patients with chronic hepatitis B, during treatment, not only does PEG-IFN-α play a direct antiviral effect but it also stimulates immune cells, which results in removing virus-infected hepatocytes [24]. This evidence concerns the gene IFNA2 and chronic hepatitis B virus infection.